Liquid-Liquid Phase Separation (LLPS)

Thu, 20 Nov 2025 00:00:00 +0000

Table of Contents

概述

液-液相分離（Liquid-Liquid Phase Separation, LLPS）是細胞內生物大分子通過多價相互作用自發形成無膜細胞器（membraneless organelles）的物理化學過程。這些動態的生物分子凝聚體（biomolecular condensates）在時空上組織生化反應，實現快速、可逆的功能調控。

在核生物學中，LLPS驅動形成：

轉錄凝聚體：濃縮轉錄因子和共激活因子，增強基因激活
異染色質區域：通過HP1α等蛋白相分離維持基因沉默
DNA修復病灶：招募修復蛋白，加速損傷響應

與本項目的關聯：p53通過其固有無序區（IDR）驅動相分離，形成轉錄凝聚體，在與組蛋白的競爭中局部增強濃度，克服核小體屏障。

Overview

Liquid-Liquid Phase Separation (LLPS) is a physicochemical process by which cellular biomacromolecules spontaneously form membraneless organelles through multivalent interactions. These dynamic biomolecular condensates spatiotemporally organize biochemical reactions, enabling rapid and reversible functional regulation.

In nuclear biology, LLPS drives the formation of:

Transcriptional condensates: Concentrating transcription factors and coactivators to enhance gene activation
Heterochromatin domains: Maintaining gene silencing through phase separation of proteins like HP1α
DNA repair foci: Recruiting repair proteins to accelerate damage response

Connection to this project: p53 drives phase separation through its intrinsically disordered regions (IDRs), forming transcriptional condensates that locally enhance its concentration to overcome nucleosome barriers in competition with histones.

Figure: Major LLPS-driven biomolecular condensates in cells
Source: Banani et al. (2017) Nat Rev Mol Cell Biol 18:285-298

Section 1: LLPS基礎概念

1.1 定義與核心驅動力

什麼是LLPS？

LLPS是指均一溶液在特定條件下（濃度、溫度、離子強度）分離成兩相：

稀相（dilute phase）：蛋白濃度低，類似體相
緻密相（dense phase）：蛋白濃度高，形成液滴狀凝聚體

核心驅動力：

多價相互作用（Multivalent interactions）
- 多個弱相互作用位點的協同效應
- 通過降低體系自由能驅動相分離 ( )
固有無序區（IDRs）
- 缺乏固定三維結構
- 富含帶電、芳香族或極性氨基酸
- 提供多個可逆結合位點
特異性相互作用類型：
- π-π堆積：芳香族殘基（Phe, Tyr, Trp）
- 靜電相互作用：正負電荷吸引
- 疏水作用：疏水殘基聚集
- 氫鍵網絡：極性殘基介導

Section 1: LLPS Fundamentals

1.1 Definition and Core Driving Forces

What is LLPS?

LLPS refers to the separation of a homogeneous solution into two phases under specific conditions (concentration, temperature, ionic strength):

Dilute phase: Low protein concentration, similar to bulk
Dense phase: High protein concentration, forming droplet-like condensates

Core Driving Forces:

Multivalent interactions
- Synergistic effects of multiple weak interaction sites
- Drive phase separation by reducing system free energy ( )
Intrinsically Disordered Regions (IDRs)
- Lack fixed 3D structure
- Enriched in charged, aromatic, or polar amino acids
- Provide multiple reversible binding sites
Specific Interaction Types:
- π-π stacking: Aromatic residues (Phe, Tyr, Trp)
- Electrostatic interactions: Attraction between opposite charges
- Hydrophobic effect: Clustering of hydrophobic residues
- Hydrogen bond networks: Mediated by polar residues

1.2 分子基礎

IDR的特徵：

序列組成：
- 低複雜度序列（LCD）：重複的短氨基酸motif
- Prion-like domains（PrLDs）：類朊病毒結構域（Gln/Asn富集）
- RGG/FG重複：RNA結合蛋白常見
結構特性：
- 無固定二級/三級結構
- 構象高度靈活（ensemble of states）
- 響應環境快速變化

關鍵氨基酸類型：

類型	代表氨基酸	作用機制
芳香族	Phe, Tyr, Trp	π-π堆積，疏水作用
帶正電	Arg, Lys	靜電相互作用，結合DNA/RNA
帶負電	Glu, Asp	靜電相互作用，調控相分離閾值
極性	Ser, Thr, Gln, Asn	氫鍵網絡，穩定液滴
小分子	Gly, Ala	提供構象靈活性

實例：

p53的TAD（1-67）：富含Phe/Trp（π-π）+ 酸性殘基（靜電）
HP1α的Hinge：帶正電IDR，結合H3K9me3並驅動相分離
FUS的LCD：Gly/Ser/Gln/Tyr富集，形成水凝膠狀液滴

1.2 Molecular Basis

IDR Characteristics:

Sequence Composition:
- Low Complexity Domains (LCDs): Repetitive short amino acid motifs
- Prion-like Domains (PrLDs): Enriched in Gln/Asn
- RGG/FG repeats: Common in RNA-binding proteins
Structural Properties:
- No fixed secondary/tertiary structure
- Highly flexible conformation (ensemble of states)
- Rapid response to environmental changes

Key Amino Acid Types:

Type	Representative AAs	Mechanism
Aromatic	Phe, Tyr, Trp	π-π stacking, hydrophobic effect
Positively charged	Arg, Lys	Electrostatic interactions, DNA/RNA binding
Negatively charged	Glu, Asp	Electrostatic interactions, regulate phase separation threshold
Polar	Ser, Thr, Gln, Asn	Hydrogen bond networks, stabilize droplets
Small	Gly, Ala	Provide conformational flexibility

Examples:

p53 TAD (1-67): Rich in Phe/Trp (π-π) + acidic residues (electrostatic)
HP1α Hinge: Positively charged IDR, binds H3K9me3 and drives phase separation
FUS LCD: Enriched in Gly/Ser/Gln/Tyr, forms hydrogel-like droplets

1.3 關鍵物理特性

濃度閾值（Saturation concentration, Csat）：

超過此濃度時發生相分離
受溫度、鹽濃度、pH、分子擁擠等影響
細胞通過調控濃度控制凝聚體形成

動態流動性：

凝聚體內分子快速交換（秒-分鐘級）
FRAP實驗：螢光恢復半衰期 t₁/₂ ~ 10-100 s
不同於固體聚集體（如澱粉樣蛋白）

環境因素影響：

因素	效應	機制
溫度↑	相分離減弱	增加熵，破壞弱相互作用
鹽濃度↑	雙向調節	低鹽促進（屏蔽同種電荷），高鹽抑制（競爭結合）
分子擁擠	促進相分離	排除體積效應，降低Csat
翻譯後修飾	精細調節	磷酸化通常抑制，甲基化/乙醯化促進

相圖示例：

1.3 Key Physical Properties

Saturation Concentration (Csat):

Phase separation occurs above this concentration
Influenced by temperature, salt, pH, molecular crowding
Cells control condensate formation by regulating concentration

Dynamic Fluidity:

Rapid molecular exchange within condensates (seconds-minutes)
FRAP experiments: Fluorescence recovery half-time t₁/₂ ~ 10-100 s
Distinct from solid aggregates (e.g., amyloid)

Environmental Factors:

Factor	Effect	Mechanism
Temperature↑	Weaken phase separation	Increase entropy, disrupt weak interactions
Salt↑	Biphasic regulation	Low salt promotes (screen like charges), high salt inhibits (compete for binding)
Molecular crowding	Promote phase separation	Excluded volume effect, lower Csat
Post-translational modifications	Fine-tuning	Phosphorylation usually inhibits, methylation/acetylation promote

Phase Diagram Example:

Figure: Phase diagram showing nucleation and spinodal decomposition mechanisms
Source: Alberti et al. (2019) Cell 176:419-434

兩種形成機制：

成核（Nucleation）：濃度略超閾值時，小液滴逐漸長大
旋節分解（Spinodal decomposition）：濃度遠超閾值時，快速形成網絡狀凝聚體

詳細物理原理見

Two Formation Mechanisms:

Nucleation: Small droplets gradually grow when concentration slightly exceeds threshold
Spinodal decomposition: Rapid network formation when concentration far exceeds threshold

For detailed physical principles, see

Section 2: LLPS在核生物學中的作用

2.1 轉錄調控中的LLPS

轉錄凝聚體的形成

轉錄激活需要轉錄因子（TFs）、共激活因子、Mediator複合體和RNA Pol II在特定基因位點的協同作用。LLPS提供了一種時空濃縮機制：

超級增強子（Super-enhancers）的相分離：

多個增強子簇集形成高濃度TF結合位點
Mediator的MED1亞基（含IDR）驅動相分離
形成轉錄工廠（transcription factories）
排除抑制因子，選擇性富集激活因子

關鍵轉錄凝聚體：

凝聚體類型	核心蛋白	驅動區域	功能
p53凝聚體 ⭐	p53	TAD (1-67)	應激響應，細胞週期阻滯
MYC凝聚體	MYC, MAX	N-terminal LCD	生長調控，代謝重編程
ER凝聚體	ER, Mediator	IDR + AF2	雌激素響應
GCN4凝聚體	GCN4, Mediator	Acidic AD	營養缺乏響應

p53凝聚體與組蛋白競爭 ⭐⭐⭐

p53如何通過相分離克服核小體屏障：

基礎狀態（無應激）：
- p53濃度低（~10 nM）
- 組蛋白佔據優勢（~10 μM）
- 核小體緊密包裝DNA，p53結合位點被遮蔽
應激激活（DNA損傷）：
- ATM/ATR磷酸化 → p53穩定化
- p53濃度劇增（~1 μM）
- TAD驅動相分離形成凝聚體
局部濃度增強：
- 凝聚體內p53濃度：~100 μM
- 遠超體相濃度，改變競爭平衡
- 利用核小體呼吸窗口（50-250 ms）結合DNA
招募染色質重塑酶：
- p53凝聚體招募p300/CBP（HAT活性）
- 組蛋白乙醯化 → 核小體不穩定
- SWI/SNF複合體移除核小體
維持開放染色質：
- 相分離持續存在（分鐘-小時）
- 防止核小體快速重新組裝
- 持續轉錄激活

實驗證據：

Chong et al. (2018): 體外重構p53液滴
Guo et al. (2019): 活細胞成像觀察p53病灶

MYC-p53 Sequential Remodeling假說：

增殖期：MYC凝聚體主導 → 增殖基因激活
複製壓力：R-loop形成 → DNA損傷
狀態轉換：MYC凝聚體解體，p53凝聚體形成
修復狀態：p53凝聚體主導 → 修復基因激活

Section 2: LLPS Roles in Nuclear Biology

2.1 LLPS in Transcriptional Regulation

Formation of Transcriptional Condensates

Transcriptional activation requires cooperative action of transcription factors (TFs), coactivators, Mediator complex, and RNA Pol II at specific gene loci. LLPS provides a spatiotemporal concentration mechanism:

Super-enhancer Phase Separation:

Multiple enhancer clusters form high-density TF binding sites
Mediator’s MED1 subunit (containing IDR) drives phase separation
Form transcription factories
Exclude repressors, selectively enrich activators

Key Transcriptional Condensates:

Condensate Type	Core Proteins	Driving Region	Function
p53 condensate ⭐	p53	TAD (1-67)	Stress response, cell cycle arrest
MYC condensate	MYC, MAX	N-terminal LCD	Growth control, metabolic reprogramming
ER condensate	ER, Mediator	IDR + AF2	Estrogen response
GCN4 condensate	GCN4, Mediator	Acidic AD	Nutrient starvation response

p53 Condensates and Histone Competition ⭐⭐⭐

How p53 Overcomes Nucleosome Barriers via Phase Separation:

Basal State (No Stress):
- Low p53 concentration (~10 nM)
- Histones dominate (~10 μM)
- Nucleosomes tightly package DNA, p53 binding sites occluded
Stress Activation (DNA Damage):
- ATM/ATR phosphorylation → p53 stabilization
- p53 concentration surges (~1 μM)
- TAD-driven phase separation forms condensates
Local Concentration Enhancement:
- p53 concentration inside condensates: ~100 μM
- Far exceeds bulk concentration, shifts competitive equilibrium
- Exploit nucleosome breathing windows (50-250 ms) to bind DNA
Recruit Chromatin Remodelers:
- p53 condensates recruit p300/CBP (HAT activity)
- Histone acetylation → nucleosome destabilization
- SWI/SNF complex removes nucleosomes
Maintain Open Chromatin:
- Phase separation persists (minutes-hours)
- Prevent rapid nucleosome reassembly
- Sustain transcriptional activation

Experimental Evidence:

Chong et al. (2018): In vitro reconstitution of p53 droplets
Guo et al. (2019): Live-cell imaging of p53 foci

MYC-p53 Sequential Remodeling Hypothesis:

Proliferation phase: MYC condensate dominates → proliferation gene activation
Replication stress: R-loop formation → DNA damage
State transition: MYC condensate dissolves, p53 condensate forms
Repair state: p53 condensate dominates → repair gene activation

2.2 染色質組織中的LLPS

HP1α驅動的異染色質形成

機制：

識別：HP1α的Chromodomain識別H3K9me3
二聚化：HP1α同源二聚體形成
相分離：Hinge區（IDR）介導多價相互作用
擴散：HP1α液滴招募更多HP1α和HMT（如SUV39H）
正反饋：新甲基化的H3K9me3進一步招募HP1α

特性：

液滴直徑：0.2-2 μm
FRAP恢復時間：~30 s
排除RNA Pol II和轉錄激活因子
維持基因沉默狀態

Polycomb body形成

核心成分：

PRC1/PRC2複合體
CBX蛋白（識別H3K27me3）
EZH2（催化H3K27me3）

功能：

Polycomb靶基因共定位
形成抑制性核區域
發育基因的長程沉默

其他核凝聚體

凝聚體	核心蛋白	功能
核仁	Nucleolin, Fibrillarin	rRNA轉錄與加工
核斑點	SRSF2, SON	mRNA剪接因子儲存
PML body	PML, SUMO	應激響應，腫瘤抑制
Cajal body	Coilin	snRNA成熟

2.2 LLPS in Chromatin Organization

HP1α-Driven Heterochromatin Formation

Mechanism:

Recognition: HP1α Chromodomain recognizes H3K9me3
Dimerization: HP1α homodimer formation
Phase Separation: Hinge region (IDR) mediates multivalent interactions
Spreading: HP1α droplets recruit more HP1α and HMTs (e.g., SUV39H)
Positive Feedback: Newly methylated H3K9me3 further recruits HP1α

Properties:

Droplet diameter: 0.2-2 μm
FRAP recovery time: ~30 s
Exclude RNA Pol II and transcriptional activators
Maintain gene silencing state

Polycomb Body Formation

Core Components:

PRC1/PRC2 complexes
CBX proteins (recognize H3K27me3)
EZH2 (catalyzes H3K27me3)

Functions:

Co-localization of Polycomb target genes
Form repressive nuclear domains
Long-range silencing of developmental genes

Other Nuclear Condensates

Condensate	Core Proteins	Function
Nucleolus	Nucleolin, Fibrillarin	rRNA transcription & processing
Nuclear speckles	SRSF2, SON	mRNA splicing factor storage
PML body	PML, SUMO	Stress response, tumor suppression
Cajal body	Coilin	snRNA maturation

2.3 DNA損傷修復中的LLPS

修復病灶的液滴性質

雙鏈斷裂（DSB）響應：

初始信號：γH2AX標記損傷位點
53BP1招募：
- 53BP1低複雜度區域驅動相分離
- 形成微米級病灶（修復工廠）
- 濃縮BRCA1, Rad51等修復蛋白
動態流動性：
- FRAP實驗證實液滴特性
- 允許修復蛋白快速交換
- 根據修復進程動態重組

功能優勢：

濃縮效應：提高局部酶濃度，加速修復
選擇性分配：排除不相關蛋白，避免干擾
可逆性：修復完成後快速解散

病理意義：

過度穩定的液滴 → 修復延遲
相分離缺陷 → 基因組不穩定性
靶向液滴動態 → 潛在治療策略

2.3 LLPS in DNA Damage Repair

Liquid Droplet Properties of Repair Foci

Double-Strand Break (DSB) Response:

Initial Signal: γH2AX marks damage site
53BP1 Recruitment:
- 53BP1 low-complexity region drives phase separation
- Forms micrometer-scale foci (repair factories)
- Concentrates BRCA1, Rad51, and other repair proteins
Dynamic Fluidity:
- FRAP experiments confirm droplet properties
- Allow rapid exchange of repair proteins
- Dynamically reorganize according to repair progress

Functional Advantages:

Concentration Effect: Increase local enzyme concentration, accelerate repair
Selective Partitioning: Exclude irrelevant proteins, avoid interference
Reversibility: Rapidly disassemble after repair completion

Pathological Significance:

Overly stable droplets → repair delay
Phase separation defects → genomic instability
Targeting droplet dynamics → potential therapeutic strategies

Section 3: 關鍵LLPS驅動蛋白

下表列出了主要的LLPS驅動蛋白及其特徵。⭐ 標記的蛋白與本項目研究重點相關。

Section 3: Key LLPS-Driving Proteins

The table lists major LLPS-driving proteins and their characteristics. ⭐ marks proteins related to project research focus.

Category	Protein	LLPS-Driving Region	Function	Details
轉錄因子 Transcription Factors	p53 ⭐⭐⭐	TAD (aa 1-67) Aromatic + Acidic	Stress response, cell cycle arrest, tumor suppression	View →
	MYC	N-terminal LCD (aa 1-143) Charged residues	Growth control, metabolic regulation	Planned
	NFAT5	Auxiliary domain IDR	Osmotic stress response	—
	GCN4	Acidic activation domain	Amino acid starvation response	—
染色質蛋白 Chromatin Proteins	HP1α ⭐⭐	Hinge (aa 70-120) Positively charged IDR	Heterochromatin formation, gene silencing	View →
	PRC1 (CBX2)	C-terminal IDR (aa 300-532) Low complexity	Polycomb body formation	—
	BRD4	IDR Intrinsically disordered	Super-enhancer assembly, transcription elongation	—
	TIP5	IDR + RNA-binding	Nucleolar silencing	—
共激活因子 Coactivators	Mediator (MED1) ⭐	IDR (aa 1-580) Super-enhancer driver	Transcription factory formation	—
	p300/CBP	CH1-KIX-CH3 linkers IDR	Histone acetylation, chromatin opening	—
	YAP/TAZ	C-terminal IDR	Hippo pathway, mechanotransduction	—
	NELF	RRM + IDR	Transcription pausing control	—

關鍵蛋白的IDR結構特徵

下表總結了主要LLPS驅動蛋白的IDR位置、序列特徵和驅動機制：

IDR Structural Features of Key Proteins

The table summarizes the IDR positions, sequence features, and driving mechanisms of major LLPS-driving proteins:

Protein	IDR Region (aa)	Key Residues	Driving Mechanism	Csat (approx.)
p53	TAD (1-67) CTD (363-393)	Phe, Trp (π-π) Glu, Asp (electrostatic)	Aromatic stacking + Electrostatic	~0.5 μM
MYC	N-term (1-143)	Charged residues (Arg, Glu)	Electrostatic interactions	~2 μM
HP1α	Hinge (70-120)	Arg, Lys (positive) RNA-binding	Electrostatic + RNA bridging	~1 μM
CBX2	C-term (300-532)	Low complexity	Weak multivalent interactions	~5 μM
MED1	IDR (1-580)	Ser, Thr, Gln-rich	Polar interactions + TF binding	~0.1 μM
FUS	LCD (1-267)	Gly, Ser, Gln, Tyr	π-π + Hydrogen bonds	~0.05 μM

表格說明：

Csat：體外測定的相分離濃度閾值（實際細胞內受多種因素調控）
高亮行：與本項目研究重點相關（p53, HP1α, MED1）
FUS：RNA結合蛋白，作為經典LLPS模型蛋白列出

Table Notes:

Csat: In vitro measured phase separation concentration threshold (regulated by multiple factors in cells)
Highlighted rows: Related to project research focus (p53, HP1α, MED1)
FUS: RNA-binding protein, listed as a classical LLPS model protein

LLPS | Dr. Yu-Ting Sun - Biophysicist & Researcher